HopeStage
Back to all studies
CompletedNCT04563078

Effect of TMS on PTSD Biomarkers

It focuses on PTSD and currently lists study information in the United States.

PTSDDeviceFrom 18 Years to 65 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Atlanta, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: February 15, 2021
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
Emory University
Sponsor type
University
Study type
Device
Intervention type
DEVICE, PROCEDURE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04563078
Official title
Effect of Transcranial Magnetic Stimulation (TMS) on PTSD Neuroimaging and Psychophysiological Biomarkers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Atlanta

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Emory University, a university.

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me